ArticleClinicoEconomics and outcomes research : CEOR2016

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand.

Unchalee Permsuwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.